Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen
- PMID: 11390467
- DOI: 10.4049/jimmunol.166.12.7190
Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen
Abstract
Human lymphocytes expressing the gammadelta TCR represent a minor T cell subpopulation found in blood. The majority of these cells express Vgamma9Vdelta2 determinants and respond to nonpeptidic phosphoantigens. Several studies have shown that, in vivo, the percentage of Vgamma9Vdelta2 T cells dramatically increases during pathological infection, leading to the hypothesis that they play an important role in the defense against pathogens. However, the specific mechanisms involved in this response remain poorly understood. It has been established that Vgamma9Vdelta2 T cells display potent cytotoxic activity against virus-infected and tumor cells, thereby resembling NK cells. In this study, we show that, upon stimulation by nonpeptidic Ags, Vgamma9Vdelta2 T cells express FcgammaRIIIA (CD16), a receptor that is constitutively expressed on NK cells. CD16 appears to be an activation Ag for Vgamma9Vdelta2 T cells. Indeed, ligation of CD16 on Vgamma9Vdelta2 T cells leads to TNF-alpha production. This TNF-alpha production, which is dependent (like that induced via the TCR-CD3 complex) on the activation of the p38 and extracellular signal-regulated kinase-2 mitogen-activated protein kinases, can be modulated by CD94 NK receptors. Therefore, it appears that Vgamma9Vdelta2 T cells can be physiologically activated by two sequential steps via two different cell surface Ags: the TCR-CD3 complex and the FcgammaRIIIA receptor, which are specific cell surface Ags for T lymphocytes and NK cells, respectively. This strongly suggests that, in the general scheme of the immune response, Vgamma9Vdelta2 T cells represent an important subpopulation of cells that play a key role in the defense against invading pathogens.
Similar articles
-
CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.J Immunol. 1997 Dec 15;159(12):6009-17. J Immunol. 1997. PMID: 9550399
-
Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands.J Exp Med. 1997 Nov 17;186(10):1769-74. doi: 10.1084/jem.186.10.1769. J Exp Med. 1997. PMID: 9362537 Free PMC article.
-
Specific signaling pathways triggered by IL-2 in human V gamma 9V delta 2 T cells: an amalgamation of NK and alpha beta T cell signaling.J Immunol. 2003 Nov 15;171(10):5225-32. doi: 10.4049/jimmunol.171.10.5225. J Immunol. 2003. PMID: 14607923
-
Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?Vaccine. 2002 May 6;20(15):1938-41. doi: 10.1016/s0264-410x(02)00070-1. Vaccine. 2002. PMID: 11983250 Review.
-
ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.Front Immunol. 2018 Jun 8;9:1246. doi: 10.3389/fimmu.2018.01246. eCollection 2018. Front Immunol. 2018. PMID: 29937767 Free PMC article. Review.
Cited by
-
Correlation analysis between immune-related genes and cell infiltration revealed prostate cancer immunotherapy biomarkers linked to T cells gamma delta.Sci Rep. 2023 Feb 11;13(1):2459. doi: 10.1038/s41598-023-28475-6. Sci Rep. 2023. PMID: 36774376 Free PMC article.
-
γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends.Front Immunol. 2021 Sep 22;12:729085. doi: 10.3389/fimmu.2021.729085. eCollection 2021. Front Immunol. 2021. PMID: 34630403 Free PMC article. Review.
-
The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?Cancer Immunol Immunother. 2021 Jul;70(7):1797-1809. doi: 10.1007/s00262-020-02805-3. Epub 2021 Jan 1. Cancer Immunol Immunother. 2021. PMID: 33386466 Free PMC article. Review.
-
Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.Front Immunol. 2017 Jun 30;8:761. doi: 10.3389/fimmu.2017.00761. eCollection 2017. Front Immunol. 2017. PMID: 28713381 Free PMC article. Review.
-
Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti- versus Pro-Tumoral Activities.Front Immunol. 2017 Aug 28;8:1041. doi: 10.3389/fimmu.2017.01041. eCollection 2017. Front Immunol. 2017. PMID: 28894450 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous